Cytosorbents
(NASDAQ) CTSO
Cytosorbents Financials at a Glance
Market Cap
$36.55M
Revenue (TTM)
$37.06M
Net Income (TTM)
$8.20M
EPS (TTM)
$-0.13
P/E Ratio
-4.37
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.57
Volume
253,024
Open
$0.59
Price
$0.57
Volume
253,024
Open
$0.59
Previous Close
$0.58
Daily Range
$0.53 - $0.59
52-Week Range
$0.50 - $1.39
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.57
Volume
253,024
Open
$0.59
Previous Close
$0.58
Daily Range
$0.53 - $0.59
52-Week Range
$0.50 - $1.39
CTSO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cytosorbents
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
129
CEO
Phillip P. Chan, MD, PhD
Website
cytosorbents.comHeadquarters
Princeton, NJ 08540, US
CTSO Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
-39%
Net Income Margin
-22%
Return on Equity
-96%
Return on Capital
-42%
Return on Assets
-19%
Earnings Yield
-22.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$36.55M
Shares Outstanding
62.70M
Volume
253.02K
Short Interest
0.00%
Avg. Volume
88.29K
Financials (TTM)
Gross Profit
$26.49M
Operating Income
$14.24M
EBITDA
$12.74M
Operating Cash Flow
$12.38M
Capital Expenditure
$164.00K
Free Cash Flow
$12.54M
Cash & ST Invst.
$6.25M
Total Debt
$29.11M
Cytosorbents Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.23M
+0.9%
Gross Profit
$6.80M
-27.6%
Gross Margin
73.68%
N/A
Market Cap
$36.55M
N/A
Market Cap/Employee
$245.33K
N/A
Employees
149
N/A
Net Income
$5.50M
+30.3%
EBITDA
$3.69M
+56.7%
Quarterly Fundamentals
Net Cash
$22.86M
+3.2%
Accounts Receivable
$7.55M
+3.1%
Inventory
$5.28M
+93.2%
Long Term Debt
$28.57M
+8.1%
Short Term Debt
$541.00K
+19.5%
Return on Assets
-18.56%
N/A
Return on Invested Capital
-41.82%
N/A
Free Cash Flow
$4.89M
-98.2%
Operating Cash Flow
$4.83M
-106.0%